Neil L. Spector, MD
Dr. Spector received his MD from the University of Medicine and Dentistry of New Jersey–New Jersey Medical School in 1982. He is Associate Professor of Medicine and Associate Professor of Pharmacology & Cancer Biology at Duke University School of Medicine. Dr. Spector's current clinical interests include inflammatory breast cancer; HER2+ breast cancer; development of targeted therapies; developmental therapeutics; and personalized medicine.
Gregory P. Samsa, PhD
Dr. Samsa received his PhD from the University of North Carolina at Chapel Hill in 1988. He is Associate Professor of Biostatistics and Bioinformatics and Assistant Professor in Medicine at Duke University School of Medicine. Dr. Samsa is an applied statistician whose primary interests are in study design, instrument development, information synthesis, practice improvement, effective communication of statistical results, and teaching.
Herbert Pang, PhD
Dr. Pang received his PhD from Yale University in 2008. He is Assistant Professor of Biostatistics and Bioinformatics at Duke University School of Medicine. Dr. Pang's current research interests include classification and predictive models, design and analysis of biomarker clinical trials, genomics and pathway analysis.
David H. Harpole Jr., MD
Dr. Harpole received his MD from the University of Virginia School of Medicine in 1984. He is Professor of Surgery and Associate Professor in Pathology at Duke University School of Medicine. Dr. Harpole's current research interests include thoracic oncology; general thoracic surgery; benign and malignant disease of the lung, esophagus, and mediastinum; advanced airway and thoracoscopic surgery; hyperhidrosis palmaris; and mesothelioma.
Jeffrey Crawford, MD
Dr. Crawford received his MD from Ohio State University College of Medicine in 1974. He is Professor of Medicine and Chief of the Division of Medical Oncology at Duke University School of Medicine. Dr. Crawford's current research interests include lung cancer (small-cell and non-small-cell), chemotherapy, hematopoietic growth factors, and cancer clinical trials.
Kimberly L. Blackwell, MD
Dr. Blackwell received her MD from Mayo Medical School in 1994. She is Professor of Medicine and Assistant Professor in Radiation Oncology at Duke University School of Medicine. Dr. Blackwell's current research interests include breast cancer angiogenesis, breast cancer in younger women, hormonal therapy, and neoadjuvant therapy for breast cancer.
Amy P Abernethy, MD
Dr. Abernethy received her MD from Duke University School of Medicine in 1994. She is Associate Professor of Medicine Department of Medicine, Division of Medical Oncology at Duke University School of Medicine and Associate Professor of Nursing at Duke University School of Nursing. Dr. Abernethy directs the Center for Learning Healthcare (CLHC) in the Duke Clinical Research Institute. She also directs the Duke Cancer Care Research Program (DCCRP), a part of the CLHC that connects to the Duke Cancer Institute.